A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer

Clinical trial NCT07078604 · RECRUITING

Trial details

NCT number: NCT07078604
Sponsor: University of Washington
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Metastatic Triple-Negative Breast Carcinoma

Start date: 2026-03-24
Primary completion: 2027-04-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.